Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
deafness, ocular lesions, and progressive renal failure [1] . The pathogenesis of Alport syndrome has been linked to defects of type IV collagen, which is a major structural component of basement membranes. The majority of cases (about 85%) are caused by mutations in the COL4A5 gene on the X chromosome which encodes the a5(IV) chain (X-linked Alport syndrome) [2] . Since the first COL4A5 mutations were described by Barker et al [3] , more than 300 mutations of various types have been identified in X-linked Alport syndrome patients [4] [5] [6] . At present, an integrative approach involving clinical, histopathologic and pedigree analysis allows accurate diagnosis of X-linked Alport syndrome in most patients and can be accomplished in many centers. In regards to genetic diagnosis, most methods for COL4A5 mutation screening have involved polymerase chain reactionsingle strand conformation polymorphism (PCR-SSCP) or PCR and direct sequencing based on genomic DNA [4] [5] [6] [7] . Detection of mutations by reverse transcription (RT)-PCR and direct sequencing based on the illegitimate transcription of the COL4A5 gene in leukocytes or hair roots appears to be a relatively insensitive approach [8, 9] . So far the highest total detection sensitivity of COL4A5 mutations in evident X-linked Alport syndrome (including males and females) has been about 80% using genomic DNA or RNA from leukocytes [5, 8] . However, these methods have two important disadvantages. First, the COL4A5 gene spans 250 kb of the human genome and contains 51 exons. Mutation screening strategies based on genomic DNA sequencing are quite laborious and expensive. Labor and expense are further increased by the need to establish Epstein-Barr virus transformed cell lines in order to extract sufficient total RNA [8, 10] . Second, some variants are underdetected by these methods, for instance, the intronic sequence variations that might cause splicing abnormalities as shown by King et al [9] . Therefore, we set out to develop methods identifying COL4A5 mutations with a high rate of sensitivity, while limiting costs associated with labor and materials.
It has been demonstrated that a5(IV) chain distributed in several basement membranes of the kidney, skin, and cochlea [11] . The immunofluorescence staining with antia5(IV) antibody in the normal epidermal basement membrane (EBM) also displayed the existence of mRNA and protein encoded by COL4A5 gene [12, 13] . Several studies have documented that a1(IV), a5(IV), and a6(IV) transcripts were expressed in cultures of dermal fibroblasts [14, 15] . It was especially important that the mRNA level of a5(IV) chain in fibroblasts of the patient with COL4A5 mutations was similar to that of controls [15] . Therefore, we speculated that skin fibroblasts could be a cellular source of mRNA for COL4A5 mutation analysis in X-linked Alport syndrome.
In this study, a simple and fast approach for systematic gene analysis in X-linked Alport syndrome patients was established. RT-PCR conditions were optimized to amplify the COL4A5 cDNA in five overlapping fragments from RNA isolated from skin fibroblasts. The systematic analysis of the entire coding region of COL4A5 mRNA in 31 unrelated Chinese X-linked Alport syndrome patients and four controls was carried out using RT-PCR and direct sequencing. The entire sequences of the mRNA of the controls corresponded exactly to the published sequence [16] . A total of 25 functionally significant COL4A5 gene mutations was detected in 25/31 patients using RT-PCR method and subsequently confirmed at the genomic DNA level. The mutation detection rate was 80.6% (25/31). Interestingly, among 28 variants detected in this study, three splicing mutations that occurred at cryptic splice sites and might be missed by genomic DNA sequencing were identified. The results demonstrate that RT-PCR and direct sequencing using skin fibroblasts can be applied as a sensitive and practical method for detecting mutations in the COL4A5 gene.
METHODS

Patients
A total of 31 unrelated patients diagnosed as X-linked Alport syndrome, 22 males and nine females, were included in the study. The average age of these individuals was 17.8 years (range 2 to 45 years). All patients were diagnosed by fulfilling at least three of the four diagnostic criteria for Alport syndrome as proposed by Flinter et al [17] . In addition, each patient exhibited abnormal distributions of a3(IV), a4(IV) and a5(IV) chains in the glomerular basement membrane (GBM) or abnormal distribution of a5(IV) chain in the EBM [12, 18, 19] . Although, according to literatures, the abnormal staining of a(IV) chains on basement membrane is only in 70% to 80% of X-linked Alport syndrome patients [19] (our unpublished data showed in 96% of X-linked Alport syndrome patients), the 31 patients in this study were selected with the confirmed clinical diagnosis of Xlinked Alport syndrome, and were further undergone the COL4A5 mutational analysis. The clinical features of the patients were shown in Table 1 .
Skin fibroblast cultures
After informed consent from these patients and their family members, skin punch biopsy specimens (5 mm in diameter and 1 mm in depth) were obtained from the volar aspect of the forearm. Two thirds of the skin specimens were for indirect immunofluorescence determination of a5(IV) chain, and the remaining one third was used as material for cell culture. Skin biopsy specimens obtained from four patients with other renal diseases were used as control subjects.
The skin specimens were washed in 0.01 mol/L phosphate-buffered saline (PBS) solution and in Dulbecco's modified Eagle's medium (DMEM). Epithelium and fat were carefully trimmed away. Then the minced pieces of 1 to 2 mm in size were seeded in plastic flasks with DMEM containing 20% fetal bovine serum (FBS), L-glutamine (20 mmol/L), penicillin (100 U/mL), and streptomycin (100 lg/mL) in an atmosphere of 95% air and 5% carbon dioxide at 37
• C. After the outgrowth of cells from the explant that formed a monolayer, the fibroblasts were passaged by trypsinization. Secondary cultures were maintained in the same medium but containing 10% FBS. Cell cultures were studied in passage 3 to 8.
RNA isolation and RT
As skin fibroblasts were grown to confluence in 25 cm 2 flasks, total RNA was extracted from cultured cells using Trizol reagent (Gibco, Grand Island, NY, USA) according to the manufacturer's instructions, and reverse transcribed to first-strand cDNA by using random primers and Moloney murine leukemia virus (M-MLV) reverse transcriptase (Promega Corporation, Madison, WI, USA). The concentration of RNA was determined spectrophotometrically. The integrity of RNA and the accuracy of the quantitation were checked by 1% agarose gel electrophoresis and ultraviolet light visualization.
PCR amplification of the cDNA
Five pairs of primers were designed according to the published COL4A5 sequence [16] to amplify the entire coding sequence of COL4A5 mRNA ( Table 2 ). The five amplified cDNA fragments were 1098 bp, 1091 bp, 1338 bp, 1207 bp, and 1017 bp in size, respectively, and were partially overlapping ( The pathognomonic ultrastructural feature of the Alport kidney under electron microscopy is a thickened GBM over time into multilamellations surrounding lucent areas [2] .
e Developed renal failure at the age of 25 years, and renal function remained normal after renal transplantation. f Developed renal failure at the age of 30 years, and renal function remained normal after renal transplantation. Numbers after each primer refererd to the location of the first 5 base according to [16] .
parameters were optimized as followings: an initial denaturation at 95
• C for 5 minutes, 35 cycles of denaturation (95
• C for 30 seconds), annealing (55 • C or 58
• C for 1 minute), elongation (72
• C for 2 minutes), and a final elongation for 7 minutes at 72
• C. The PCR amplification products were checked by 1% agarose gel electrophoresis and were subsequently sequenced with ABI Prism 377 Automated DNA Sequencer (Applera Corporation, San Francisco, CA, USA) with both the forward and reverse primers.
DNA analysis
When abnormal sequence was detected in the cDNA amplification products by direct sequencing, the corresponding exon with flanking intronic sequence was further amplified to confirm the abnormality. The genomic DNA was extracted from peripheral blood lymphocytes by a simple salting out procedure [20] and the exons were amplified with the published primers and conditions with a slight modification [7] . The PCR products of exons were determined by 1% agarose gel electrophoresis and then directly sequenced with DNA Sequencer as above mentioned.
RESULTS
RNA isolation and cDNA sequence of the control
The integrity of all RNA samples was determined by 1% agarose gel electrophoresis. The purity of RNA was confirmed with 260/280 optical density being 1.8 ∼ 2.0. About 7 lg of total RNA could be extracted from confluent cultured skin fibroblasts in a 25 cm 2 flask. The five overlapping PCR products obtained from skin fibroblasts of the control were successfully amplified and completely sequenced with DNA Sequencer as above mentioned. The sizes of all fragments were the same as previously designed (i.e., 1098 bp, 1091 bp, 1338 bp, 1207 bp, and 1017 bp, respectively) (Fig. 2) . The entire amplified sequence of the four controls corresponded exactly to the 5058 bp of the published COL4A5 mRNA sequence, which covered part of the 5 and 3 untranslated regions, the complete 7S, and triple-helical and carboxyterminal NC1 domains of the collagen a5(IV) molecule but without the variant exons 41A and 41B [16, 21] .
Detection of COL4A5 variants
A total of 28 different COL4A5 gene variants was detected in 28/31 patients by using RT-PCR method and subsequently confirmed at genomic DNA level (Table 3) . Some patients had more than one sequence variation. Of these, 25 of the detected COL4A5 variants that were revealed in 25 patients resulted in alterations in the amino acid sequence and were classified as functionally significant mutations. The mutation detection rate was 80.6% (25/31). Of the 28 patients, seven patients had splicing mutations (7/28) (25.0%), three had small insertions or deletions (10.7%), 12 had missense variants (42.8%), two had nonsense variants (7.1%) and four patients had more variants in one allele (14.4%). Seven splicing mutations, six missense variants, three small insertion/deletions, two nonsense variants, and three haplotypes were newly described in the present study. The other seven variants have already been reported elsewhere (Table 3) .
Splicing mutations
Seven mutations (25.0%) were identified in introns that affected splice signals and resulted in aberrant splicing of mRNA, causing complete or partial exon skipping. Four of the splicing mutations were located in the two most highly conserved 5 donor nucleotides or 3 acceptor nucleotides (↓GT or AG↓). The acceptor splice site mutation 1626 − 1G>A in family 3 resulted in skipping of the downstream exon 22. Mutations in splice donor sites in intron 25 (family 6) and in intron 46 (family 7), resulted in skipping of the upstream exon 25 and partial skipping of exon 46, respectively. In the case of the mutation in splice donor site 1718 + 1G>A in intron 22, two kinds of aberrant mRNA were induced: skipping of the upstream exon 22 and skipping of the upstream exon 22 along with the insertion of 44 bp of intron 21.
Interestingly, three splicing mutations (10.7%) occurring at atypical or cryptic splice sites were identified in the study. The mutation 1036 + 5G>T in intron 14 resulted in the loss of upstream exon 14 and the mutation 1625 + 56 1625 + 57insC led to partial skipping of upstream exon 22. The mutation 668 − 12G>A (family 1) also induced two kinds of aberrant mRNA: skipping of the upstream exon 9 and preserving exon 9 but inserting 10 bp of intron 8.
Small insertion/deletions
A single base insertion and two small deletions were found. Two of them (1486 1487insG and 1855 1856delC) a Nuleotides and amino acids were numbered according to [22] . b Nucleotides were numbered according to [16] .
caused a change in the reading frame and introduced a premature stop codon. These variants were expected to result in truncated a5(IV) chains. One in-frame deletion was found in exon 31 in family 10.
Missense variants
Thirteen different missense variants were identified in the transcript and were confirmed by genomic DNA analysis in family 11 to family 22. Among 11 different amino acid substitutions detected in the collagenous domain of a5(IV) chain, 10 were glycine substitutions which interrupt the Gly-X-Y repeat structure and disrupt folding of the triple helix. G953V was found in two apparently unrelated families and one family also had other variants. In family 12 there were two amino acid substitutions (G325R and I703V) identified. The substitution G325R has been identified as a causative mutation in X-linked Alport syndrome patient [23] , whereas the pathogenicity of the substitution I703V was not established yet in the study. Two cysteine codon changes were detected in exon 49 and 51, respectively.
Nonsense variants
Two single base substitutions resulted in the generation of a stop codon and therefore the truncation of the a5(IV) protein.
More variants in one allele
Six "silent" variants identified in the study were nucleotide changes at the third base of codons. Interestingly, four of the six "silent" variants (G365G + L685L + P783P + Q1171Q) were found on the same allele as the I444S variant and were found in three unrelated families (26, 27 , and 28). The I444S variant has been previously reported a polymorphism but not a pathogenic change [24] . In one case the "silent" variant D1425D was also present and this haplotype has already been detected [8] . The haplotype L685L + P783P + G953V found in family 25 and another haplotype G365G + I444S + L685L + P783P + Q1171Q found in both family 26 and family 27 have never been reported previously.
DISCUSSION
Alport syndrome is a clinically heterogeneous, inherited disorder of the GBM. The vast majority of Alport pedigrees show X-linked inheritance which is caused by mutations in the COL4A5 gene encoding a5(IV) chain. As the expression patterns of a5(IV) chain are nearly always identical in the GBM and EBM, and compared with a kidney biopsy, a skin biopsy is less invasive, immunohistochemical analysis of skin biopsy specimens with antia5(IV) antibody is a useful method to identify a COL4A5 gene defect [12, 13] . In our clinical practice, skin biopsy and indirect immunofluorescent analysis of a5(IV) chain in the EBM are performed routinely on patients suspected of X-linked Alport syndrome. At the same time, only a tiny piece of the skin specimen was enough to culture skin fibroblasts for RNA isolation and mutation analysis.
RT-PCR and direct sequencing from COL4A5 mRNA isolated from cultured skin fibroblasts were performed in 31 unrelated patients diagnosed as X-linked Alport syndrome. Variants that were predicted to be functionally significant were identified in 25 of the 31 patients in the present work. The mutation detection rate was 80.6%, comparable with the highest previous detection sensitivity of COL4A5 mutations in evident X-linked Alport syndrome using genomic DNA or leukocytes [5, 8] . These results show that RT-PCR and direct sequencing using skin fibroblasts RNA is a highly sensitive method for the routine genetic diagnosis of X-linked Alport syndrome patients. Each mutation identified in the study by RT-PCR and direct sequencing was confirmed on genomic DNA level, which suggested that this approach was reliable and consistent. Furthermore, this approach was simpler and more convenient methodologically comparing with the method that isolated total RNA from EpsteinBarr virus-transformed lymphocytes [8, 10] . RT-PCR and direct sequencing using RNA isolated from skin fibroblasts is much more economical than PCR-SSCP, direct sequencing of genomic DNA or RT-PCR/sequencing of lymphocyte RNA. Only five fragments covering the entire coding sequence of COL4A5 gene were sufficient for our technique, whereas previous methods of analyzing genomic DNA needed to amplify and sequence 51 exons. The material costs of identifying mutations with RNA isolated from skin fibroblasts is approximately 1/6 to 1/7 of that of performing PCR and direct sequencing with genomic DNA according to our experience and the expense in our laboratory (data not shown). Therefore, we believe our approach is more suitable and practical for institutions or laboratories with limited financial resources. A disadvantage of our approach is the time required for cell culture (3 to 4 weeks according to our own experience).
In the study, 28 variants were identified in 28 patients, including seven variants described in previous reports [4, 7, [23] [24] [25] [26] , and 21 novel variants. All variants were scattered throughout the entire coding region and involved 19 of the 51 exons. No hot spot area for mutations has been detected.
Seven splicing mutations (25.0%) were detected in the study. It is notable that three of seven splicing mutations (3/28) (10.7%) occurred at atypical or cryptic splice sites [i.e., the mutation sites that affected the splice signal located in the introns sequence except the typical splice donor and acceptor sites (↓GT or AG↓)]. It is shown from the present results that splicing mutations in COL4A5 are not always located at typical splice sites. In addition, in some cases single base mutations in exons could cause aberrant splicing in the transcript [4, 5] . It can be speculated that screening for COL4A5 mutations solely by PCR and direct sequencing using genomic DNA could overlook 10% ∼ 12.5% of cryptic splicing mutations [9] . The higher mutation detection rate in this study may be attributable to the detection of cryptic splicing mutations using RT-PCR and direct sequencing from skin fibroblasts.
It has been reported that alternatively splicing of COL4A5 mRNA existed in mRNAs from a variety of tissues. Besides the predominant isoform, there were two variants that differed from the predominant isoform by using alternative exons 41A and 41B and having one or two additional Gly-X-Y repeats [10, 21] . These variants were detected in leukocytes, kidney, placenta, liver, spleen, and thymus epithelia. The finding of differential splicing of COL4A5 mRNA in these tissues might affect their use of these tissues for the analysis of Alport variants. However, no alternatively splicing variants with 41A and/or 41B exons were found in the four controls and 31 X-linked Alport syndrome patients in the present study.
On the basis of the above results, we have shown that RT-PCR and direct sequencing using cultured skin fibroblasts RNA is a practical and feasible approach with high sensitivity for analysis of COL4A5 gene variants in Xlinked Alport syndrome patients.
